NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

CUSIP: 66737P600

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
2,147,761
Share change
-49,524
Total reported value
$1,697,062
Price per share
$0.71
Number of holders
12
Value change
-$31,707
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) as of Q3 2022

As of 30 Sep 2022, NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,147,761 shares. The largest 10 holders included Sentinus, LLC, Ancora Advisors, LLC, Moloney Securities Asset Management, LLC, Opus Capital Group, LLC, Williams Jones Wealth Management, LLC., LEE DANNER & BASS INC, GRACE & WHITE INC /NY, AlphaMark Advisors, LLC, GOFEN & GLOSSBERG LLC /IL/, and Estabrook Capital Management. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.